142nd APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Online Program

Annual Meeting Recordings are now available for purchase

309820
Using interactive voice response to improve disease management in diabetic smokers: A systematic review

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014

Danelle Guillory, MD, MPA, MT-ASCP , School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA
Sarah Moody-Thomas, PhD , School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA
Michael D. Celestin Jr., MA, CHES, CTTS , School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA
Tung-Sung Tseng, DrPH., M.S. , School of Public Health, Behavioral and Community Health Sciences Department, Louisiana State University Health Sciences Center, New Orleans, LA
Krysten Jones, MPH, CHES, CTTS , School of Public Health, Louisiana State University Health Sciences Center, Shreveport, LA
Background – Interactive Voice Response (IVR), a technology that offers voice and touch-tone response during normal phone calls, has been successfully used to support patient adherence, but is often not applied in health disparate areas in which it may be most useful.  This study reviews how IVR is used to improve smoking cessation as a component of Type II Diabetes management in diabetic smokers. 

Methods - Pubmed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and PsycINFO were searched using the following terms: interactive voice response, diabetes, smokers, tobacco, and nicotine.  Other eligibility criteria included articles between 2005 and 2013, English Language, completed interventions, Type II Diabetes (Diabetes Mellitus), and studies of human subjects.  The prevalence of IVR use and purposes of the studies were compiled and analyzed.   

Results –Zero articles met the exact search criteria.  However, fourteen articles focused on the use of IVR to improve smoking cessation (n=5) and Type II Diabetes disease management (n=9) independently. Four of five articles studied the efficacy of using IVR to improve smoking cessation in healthy populations while one concentrated on its use with Coronary Heart Disease patients. Of the nine studies on IVR utilization in diabetic populations, six used self-report data to establish feasibility of IVR use in the outpatient setting including low income regions and under-developed countries, while three demonstrated improved diabetes management using quantitative data analyses. 

Conclusions – Current IVR research primarily targets healthy smokers or feasibility testing in diabetic populations.  No studies were found that use IVR to improve smoking cessation in diabetic smokers.  These findings highlight the need for interventions that use IVR in populations of diabetic smokers to address smoking cessation as a component of disease management.

Learning Areas:

Chronic disease management and prevention

Learning Objectives:
Describe the process used to identify relevant evidence of Interactive Voice Response use to improve smoking cessation as a component of disease management in type II diabetic smokers Identify gaps in the literature on how to use Interactive Voice Response technology to improve smoking cessation as a component of disease management in type II diabetic smokers

Keyword(s): Chronic Disease Management and Care, Diabetes

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have a medical doctorate and am currently a public health doctoral student working with the Tobacco Control Initiative (TCI), a group that uses a systems approach to facilitate implementation of the US Public Health Service guideline to treat tobacco use and dependence. I have studied this topic extensively in public health classes and in my literature reviews.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3205.0: Poster session: Interventions to improve health outcomes